Annual Current Assets
$266.15 M
+$188.40 M+242.30%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual total current assets is $266.15 million, with the most recent change of +$188.40 million (+242.30%) on December 31, 2023.
- During the last 3 years, ELVN annual current assets has risen by +$135.56 million (+103.81%).
- ELVN annual current assets is now at all-time high.
Performance
ELVN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$297.00 M
-$21.13 M-6.64%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly total current assets is $297.00 million, with the most recent change of -$21.13 million (-6.64%) on September 30, 2024.
- Over the past year, ELVN quarterly current assets has dropped by -$40.20 million (-11.92%).
- ELVN quarterly current assets is now -11.92% below its all-time high of $337.20 million, reached on March 31, 2024.
Performance
ELVN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ELVN Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +242.3% | -11.9% |
| 3 y3 years | +103.8% | -0.3% |
| 5 y5 years | +103.8% | -0.3% |
ELVN Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +242.3% | -11.9% | +282.0% |
| 5 y | 5-year | at high | +242.3% | -11.9% | +282.0% |
| alltime | all time | at high | +242.3% | -11.9% | +282.0% |
Enliven Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $297.00 M(-6.6%) |
| Jun 2024 | - | $318.13 M(-5.7%) |
| Mar 2024 | - | $337.20 M(+26.7%) |
| Dec 2023 | $5.72 M | $266.15 M(-0.9%) |
| Sep 2023 | - | $268.61 M(-5.1%) |
| Jun 2023 | - | $283.18 M(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $298.00 M(+283.3%) |
| Dec 2022 | $5.54 M(+108.5%) | $77.75 M(-11.9%) |
| Sep 2022 | - | $88.23 M(-20.3%) |
| Dec 2021 | $2.66 M(+539.2%) | - |
| Dec 2021 | - | $110.67 M |
| Dec 2020 | $416.00 K | - |
FAQ
- What is Enliven Therapeutics annual total current assets?
- What is the all time high annual current assets for Enliven Therapeutics?
- What is Enliven Therapeutics annual current assets year-on-year change?
- What is Enliven Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly current assets year-on-year change?
What is Enliven Therapeutics annual total current assets?
The current annual current assets of ELVN is $266.15 M
What is the all time high annual current assets for Enliven Therapeutics?
Enliven Therapeutics all-time high annual total current assets is $266.15 M
What is Enliven Therapeutics annual current assets year-on-year change?
Over the past year, ELVN annual total current assets has changed by +$188.40 M (+242.30%)
What is Enliven Therapeutics quarterly total current assets?
The current quarterly current assets of ELVN is $297.00 M
What is the all time high quarterly current assets for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly total current assets is $337.20 M
What is Enliven Therapeutics quarterly current assets year-on-year change?
Over the past year, ELVN quarterly total current assets has changed by -$40.20 M (-11.92%)